GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Aug 2012 04:04 PM
RNS
Director/PDMR Shareholding
10 Aug 2012 03:56 PM
RNS
Director/PDMR Shareholding
10 Aug 2012 03:49 PM
RNS
Director/PDMR Shareholding
09 Aug 2012 05:03 PM
RNS
Transaction in Own Shares
09 Aug 2012 03:23 PM
RNS
Director/PDMR Shareholding
08 Aug 2012 05:04 PM
RNS
Transaction in Own Shares
07 Aug 2012 04:45 PM
RNS
Transaction in Own Shares
07 Aug 2012 03:05 PM
RNS
Director/PDMR Shareholding
06 Aug 2012 05:00 PM
RNS
Transaction in Own Shares
06 Aug 2012 03:51 PM
RNS
Director/PDMR Shareholding
03 Aug 2012 04:53 PM
RNS
Transaction in Own Shares
03 Aug 2012 07:00 AM
RNS
GSK completes the acquisition of HGS
02 Aug 2012 05:12 PM
RNS
Transaction in Own Shares
01 Aug 2012 05:07 PM
RNS
Transaction in Own Shares
01 Aug 2012 11:47 AM
RNS
Total Voting Rights
31 Jul 2012 05:00 PM
RNS
Transaction in Own Shares
30 Jul 2012 05:09 PM
RNS
Transaction in Own Shares
30 Jul 2012 01:30 PM
RNS
GSK announces initial tender offer results for HGS
27 Jul 2012 05:19 PM
RNS
Transaction in Own Shares
27 Jul 2012 12:42 PM
RNS
Director/PDMR Shareholding
26 Jul 2012 05:00 PM
RNS
Transaction in Own Shares
25 Jul 2012 12:00 PM
RNS
Half Yearly Report
23 Jul 2012 05:13 PM
RNS
Director/PDMR Shareholding
19 Jul 2012 04:10 PM
RNS
Director/PDMR Shareholding
17 Jul 2012 06:26 PM
RNS
Director/PDMR Shareholding
17 Jul 2012 03:38 PM
RNS
Director/PDMR Shareholding
16 Jul 2012 02:15 PM
RNS
GSK to acquire HGS for $14.25 per share in cash
12 Jul 2012 05:53 PM
RNS
Director/PDMR Shareholding
12 Jul 2012 05:51 PM
RNS
Director/PDMR Shareholding
12 Jul 2012 05:47 PM
RNS
Director/PDMR Shareholding
11 Jul 2012 04:00 PM
RNS
GSK announces positive data from Harmony 8 study
11 Jul 2012 03:58 PM
RNS
Director/PDMR Shareholding
11 Jul 2012 03:56 PM
RNS
Director/PDMR Shareholding
11 Jul 2012 07:00 AM
RNS
Positive data for dolutegravir vs Atripla
10 Jul 2012 05:49 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 05:47 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 05:46 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 05:44 PM
RNS
Director/PDMR Shareholding
10 Jul 2012 02:42 PM
RNS
Director/PDMR Shareholding
09 Jul 2012 03:37 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 06:03 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 05:22 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 05:02 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 04:01 PM
RNS
Director/PDMR Shareholding
06 Jul 2012 03:57 PM
RNS
Director/PDMR Shareholding
02 Jul 2012 03:42 PM
RNS
GSK concludes settlement with US Government
02 Jul 2012 03:11 PM
RNS
Director/PDMR Shareholding
02 Jul 2012 12:18 PM
RNS
Total Voting Rights
02 Jul 2012 07:00 AM
RNS
GSK announces Ph III data for LABA/LAMA in COPD
29 Jun 2012 12:00 PM
RNS
GSK sets expiration of tender offer to acquire HGS

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings